tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Balance Sheet

158 Followers

TScan Therapeutics Balance Sheet

TScan Therapeutics's total assets for Q1 2024 were $240.83M, a decrease of -11.51% from the previous quarter. TCRX total liabilities were $117.86M for the fiscal quarter, a -2.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 272.15M$ 199.09M$ 188.11M$ 49.74M$ 49.38M
Total Liabilities
$ 121.28M$ 99.66M$ 27.33M$ 92.20M$ 66.52M
Total Equity Gross Minority
$ 150.87M$ 99.43M$ 160.78M$ -42.46M$ -17.14M
Total Capitalization
$ 263.41M$ 211.03M$ 160.78M$ -42.46M$ -17.14M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 7.43M$ 4.89M
Currency in USD

TScan Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis